AstraZeneca Pharma rises 4% on getting CDSCO nod to import cancer treatment drug
- Hot Stocks
admin
- 0
- 1 minute read
AstraZeneca Pharma stock has risen 57 percent in the last one year, outperforming benchmark Nifty 50 which has risen 30 percent during the same period.
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1137356798-07a2e94fdba4405e80e24e125ae9fb74.jpg "<div>The Economics of Mexico's Middle Class</div>")